Lactoferrin and Nanotechnology: New Insights Into Glioblastoma Therapy
Atena Abed, Javad Amini Mahabadi · 2026
Read Lactoferrin and Nanotechnology: New Insights Into Glioblastoma Therapy by Atena Abed, Javad Amini Mahabadi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13575505.txt.
Description
Glioblastoma shrugs off most drugs because the blood-brain barrier keeps them out, and Atena Abed and Javad Amini Mahabadi review a smuggling strategy built on a milk protein. Lactoferrin, an iron-grabbing protein with its own anti-tumour talents, docks onto a receptor that ferries it across the barrier and into tumour cells, which display the same dock.
Wrapping chemotherapy drugs in lactoferrin-coated nanoparticles stretched their circulation two to five times and shrank tumours in animal models by roughly half, while sparing healthy tissue. The carriers also provoked tumour cell suicide and made radiation bite harder. The reviewers present the pairing as a rational platform, still preclinical, for one of medicine's most stubborn cancers.
Catalog record
| CREATOR | Atena Abed, Javad Amini Mahabadi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 45 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |